MedPath

University of North Dakota

University of North Dakota logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1883-01-01
Employees
1K
Market Cap
-
Website
http://www.und.edu

Clinical Trials

4

Active:0
Completed:3

Trial Phases

2 Phases

Phase 4:1
Not Applicable:3

Drug Approvals

1

FDA:1

Drug Approvals

Fludeoxyglucose F-18

Approval Date
Feb 10, 2015
FDA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (75.0%)
Phase 4
1 (25.0%)

Health Effects of Traditional Indigenous Chokeberry

Not Applicable
Completed
Conditions
Mental Health Wellness 1
Oxidative Stress
Inflammation
First Posted Date
2022-06-08
Last Posted Date
2023-05-01
Lead Sponsor
University of North Dakota
Target Recruit Count
46
Registration Number
NCT05410327
Locations
🇺🇸

University of North Dakota School of Medicine & Health Sciences, Grand Forks, North Dakota, United States

Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures

Not Applicable
Completed
Conditions
Lung Cancer
First Posted Date
2022-04-08
Last Posted Date
2022-11-02
Lead Sponsor
University of North Dakota
Target Recruit Count
130
Registration Number
NCT05319457
Locations
🇺🇸

University of North Dakota, Grand Forks, North Dakota, United States

Promoting Radon Testing Via Smartphone App: A Clinical Trial in a High Radon State

Not Applicable
Completed
Conditions
Lung Cancer
First Posted Date
2021-07-28
Last Posted Date
2024-08-09
Lead Sponsor
University of North Dakota
Target Recruit Count
138
Registration Number
NCT04980521
Locations
🇺🇸

University of North Dakota, Grand Forks, North Dakota, United States

A Comparison of TCC-EZ Using Human Amnion Allograft vs TCC-EZ and Standard Wound Care in Treating Diabetic Foot Ulcers.

Phase 4
Conditions
Diabetic Foot Ulcers
Diabetes
First Posted Date
2015-01-22
Last Posted Date
2017-05-09
Lead Sponsor
University of North Dakota
Target Recruit Count
12
Registration Number
NCT02344329
Locations
🇺🇸

Altru Health System, Grand Forks, North Dakota, United States

News

UND Research Team to Evaluate VR Therapy for Pediatric Amblyopia in NIH-Funded Clinical Trials

• The University of North Dakota (UND) research team has been approved to conduct clinical trials for the Pediatric Eye Disease Group (PEDIG), focusing on innovative treatments for childhood eye conditions. • The trials will assess the effectiveness of virtual reality (VR) headsets as a novel approach to treating amblyopia, also known as lazy eye, in children aged 4 to 12. • These PEDIG studies, funded by the National Eye Institute (NEI) and the National Institutes of Health (NIH), aim to compare VR therapy with traditional eye patching for amblyopia treatment. • The research could potentially change the standard of care for amblyopia, offering a more engaging and effective alternative to conventional methods.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.